openPR Logo
Press release

Global Allergic Rhinitis Market Dynamics and Development By FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm

01-10-2020 10:58 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Allergic Rhinitis Market

Global Allergic Rhinitis Market

Global allergic rhinitis market is expected to rise to an estimated value of USD 10.54 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the innovations in product development and offerings which have resulted in marketing of drugs which not only treat the symptoms but rather the cause itself.

This allergic rhinitis research report forecast 2019-2026 is a valuable source of insightful data of business strategists. It provides the industry overview with growth analysis and historical and futuristic cost, revenue, demand and supply data. The report presents market competitive landscape and a corresponding detailed analysis of the major vendor/ key players in the market.

Get Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-allergic-rhinitis-market

Few of the major competitors currently working in the global allergic rhinitis market are Merck KGaA; GSK group of companies; Sanofi; Cigna; Himalaya Wellness; Janssen Global Services, LLC; FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm; Boehringer Ingelheim International GmbH; Covis Pharma; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; ALK and Meda among others.

Key Developments in the Market:

In June 2019, ALK announced that they had finalized the marketing authorization for their tree sublingual allergy immunotherapy (SLIT) tablets, with the brand name to be expected as “ITULAZAX”. The authorization has been completed for seventeen of the countries for the European region for the treatment of allergic rhinitis. This approval will provide patients suffering from the disease a better quality of life targeting the cause of the diseases and not just treating the symptoms associated with it
In May 2019, Glenmark Pharmaceuticals announced that they had received positive conclusive evidence from their Phase 3 study of “Ryaltris”, designed for the treatment of seasonal allergic rhinitis by acting as a fixed-dose nasal spray. The study was conducted for patients aged between six and twelve, and it met the primary endpoint set forth meaning the clinical efficiency for the drug was achieved. The product depending on the approval is set to be commercialized by Glenmark Pharmaceuticals’ subsidiary “Glenmark Therapeutics Inc. USA

Inquiry For Customize Report With Discount at : https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-allergic-rhinitis-market

Segmentation: Global Allergic Rhinitis Market

By Type
(Seasonal, Perennial, Occupational Rhinitis),

Treatment
(Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids, Others),

Route of Administration
(Oral, Parenteral, Intranasal),

Form
(Solid, Liquid),

Test
(Skin Test, IgE RAST Test, Complete Blood Count),

Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Market Drivers

Increasing demand for easy to administer drugs and methods is expected to boost the growth of the market
Growing levels of strategies and collaborative practices undertaken by various manufacturers to focus on better delivery of treatment is also expected to augment growth of the market
Availability of highly-efficient workforce and resources for the efficient development and commercialization of products is also expected to boost the growth of the market
Increasing prevalence of the diseases caused by a rise in the population consuming tobacco
Market Restraints

High levels of presence in competition from generic drugs for the disease as major patents are on the verge of expiration is expected to restrict the growth of the market
Availability and increased adoption of alternative treatment modes is also expected to restrict the growth of the market

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-allergic-rhinitis-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Allergic Rhinitis Market Dynamics and Development By FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm here

News-ID: 1893651 • Views:

More Releases from Data Bridge Market Research

Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, Demand, Global Trends, Challenges and Competitive Outlook
Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, …
A crucial source of information, the Tomato Ketchup Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, Globally, by 2029: States Data Bridge Market Research
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, …
The top-notch Nitrile Butadiene Rubber (NBR) Market study has been created to offer a thorough examination of the market structure as well as projections for the various market segments and sub-segments. The purpose of this market study is to provide a thorough analysis of the market structure as well as a forecast for the various market segments and sub-segments. Consumer needs in the global market have been analyzed by key regions,
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share, Growth, Demand, Drivers, Revenue Forecast and Opportunity Analysis
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share …
Professional Footwear Market is a comprehensive and expert report that emphasizes market share, leading segments, geographic analysis, and primary and secondary drivers. A market research study includes basic, secondary, and advanced data about the state and trends of the global market as well as its size, growth, share, and segmentation as well as forecasts for the years 2023 through 2030. The study serves as the best foundation for examining competitors, evaluating
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Demand, Key Drivers, Development Trends and Competitive Outlook
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Deman …
The Nanoparticles Market research study offers a quantitative assessment of the primary obstacles that the company is facing both now and in the future. The main components of this market study are the market analysis, market definition, currency and price, significant advancements, and market classification in addition to a thorough research methodology. This market report's market study looks at a number of market segments that are predicted to grow at the

All 5 Releases


More Releases for Rhinitis

Allergic Rhinitis Pipeline involves 32+ key companies continuously working towar …
DelveInsight's 'Allergic Rhinitis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline Allergic Rhinitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Allergic Rhinitis pipeline domain. Key Takeaways from the Allergic Rhinitis Pipeline Report • DelveInsight's Allergic Rhinitis Pipeline analysis depicts a robust space with 32+ active players working to develop 32+ pipeline therapies
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non-Allergic Rhinitis T …
The Allergic Rhinitis Treatment Market was valued at US $6.95 billion in the year 2018 and is estimated to reach US $9.66 billion by 2026, at a CAGR of 4.20%. Allergic Rhinitis is inflammation caused inside the nose by allergen, also called as hay fever. Allergic Rhinitis develops when body’s immune system becomes sensitized and overreacts on exposure to allergens in the environment. It is mostly triggered by outdoor allergens like
Allergic Rhinitis Market Growing CAGR of 7% with Key Type Seasonal, Perennial an …
Global Allergic Rhinitis Market to Provide Country Level Analysis of the Market with Respect to the Current Market Size and Future Growth prospect. And also Provide Insights about Factors Affecting the Market’s Growth. Global Allergic Rhinitis Market - Scenario The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with
Allergic Rhinitis Market By Key Type Seasonal, Perennial and Non Allergic Rhinit …
Detail analysis of “Allergic Rhinitis Market” with Respect to Region Specific about Factors Affecting the market’s Growth and Various Analyses which Includes Price Analysis, Supply Chain Analysis, Porters Five Force Analysis on the Basis of Major Players Present in the Market - Forecast till 2022 Global Allergic Rhinitis Market - Scenario The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes,
Allergic Rhinitis Drugs Market Report By CMI
Introduction of new drugs is expected to drive growth of the market Manufacturers are developing a variety of drugs and nasal sprays for the treatment of allergic rhinitis. This in turn, is expected to fuel growth of the allergic rhinitis drugs market in the near future. For instance, in March 2017, the U.S. Food and Drug Administration (FDA) approved Odactra drug, manufactured by Catalent Pharma Solutions Limited, the first allergen
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non Allergic Rhinitis T …
The Allergic Rhinitis Market is segmented into types, by treatment and by test. The types of the allergic rhinitis includes seasonal, perennial and non-allergic rhinitis. On the basis of the treatment the segmentation is done into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT) and home remedies. The antihistamine segment is further sub-segmented into drugs like allegra, clarinex, xyzal and zyrtec. The decongestants segment is also sub-segmented into